Skip to main content
. 2010 Apr 7;95(9):1489–1495. doi: 10.3324/haematol.2009.018580

Figure 1.

Figure 1.

EORTC ALL-4 protocol: study design. Dxm: dexamethasone; PDN: prednisolone; CR: complete remission; PR: partial remission; HAM: high-dose cytarabine and mitoxantrone; MA: methotrexate and asparaginase; auto: autologous; allo: allogeneic; SCT: stem cell transplantation.